305 related articles for article (PubMed ID: 33497514)
1. A comparative study of combined microneedling and narrowband ultraviolet B phototherapy versus their combination with topical latanoprost in the treatment of vitiligo.
Neinaa YME; Lotfy SS; Ghaly NR; Doghaim NN
Dermatol Ther; 2021 Mar; 34(2):e14813. PubMed ID: 33497514
[TBL] [Abstract][Full Text] [Related]
2. Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB.
Stanimirovic A; Kovacevic M; Korobko I; Šitum M; Lotti T
Dermatol Ther; 2016 Sep; 29(5):312-316. PubMed ID: 27356486
[TBL] [Abstract][Full Text] [Related]
3. Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet-rich plasma for stable nonsegmental vitiligo.
Fawzy M; Al-Mokadem S; Alshereef M; Elkholy B
Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12929. PubMed ID: 37984828
[TBL] [Abstract][Full Text] [Related]
4. A comparative interventional study of narrowband ultraviolet B alone and narrowband ultraviolet B in combination with microneedling in patients with stable vitiligo.
Kaur A; Barman KD; Sahoo B; Choudhary P
Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):357-363. PubMed ID: 36419200
[TBL] [Abstract][Full Text] [Related]
5. A pilot comparative study of topical latanoprost and tacrolimus in combination with narrow-band ultraviolet B phototherapy and microneedling for the treatment of nonsegmental vitiligo.
Korobko IV; Lomonosov KM
Dermatol Ther; 2016 Nov; 29(6):437-441. PubMed ID: 27329330
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of needling/microneedling as an adjunct to phototherapy in the treatment of stable acral vitiligo: a comparative clinical and immunohistochemical study.
Esmat S; Assaf MI; Mohye Eldeen R; Gawdat HI; Saadi DG
J Dermatolog Treat; 2022 Aug; 33(5):2621-2628. PubMed ID: 35373693
[TBL] [Abstract][Full Text] [Related]
7. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.
Shin J; Lee JS; Hann SK; Oh SH
Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270
[TBL] [Abstract][Full Text] [Related]
8. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
[TBL] [Abstract][Full Text] [Related]
9. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
Vachiramon V; Chaiyabutr C; Rattanaumpawan P; Kanokrungsee S
Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
[TBL] [Abstract][Full Text] [Related]
10. Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy.
Doghaim NN; El-Tatawy RA; Ismail MA; Ali DAM; El Attar YA
J Cosmet Dermatol; 2020 Jan; 19(1):122-130. PubMed ID: 31571367
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of tofacitinib combined with narrowband ultraviolet B phototherapy for patients with refractory vitiligo in real-world clinical practice.
Song H; Hu Z; Zhang S; Yang L; Liu Y; Wang T
Dermatol Ther; 2022 Nov; 35(11):e15821. PubMed ID: 36114601
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of interrupted versus continuous narrowband ultraviolet B phototherapy in nonsegmental vitiligo treatment: A prospective randomized comparative study.
Anbar TS; Mohammed SS; Mohamed DM; Abdel-Rahman AT
Dermatol Ther; 2019 Nov; 32(6):e13117. PubMed ID: 31606939
[TBL] [Abstract][Full Text] [Related]
13. Whole-body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split-body randomized controlled trial.
Thind A; Vinay K; Mehta H; Bishnoi A; Kumaran MS; Parsad D
Photodermatol Photoimmunol Photomed; 2024 Mar; 40(2):e12960. PubMed ID: 38480997
[TBL] [Abstract][Full Text] [Related]
14. Topical Band-pass Filter Cream (TBFC)-assisted home-based NB-UVB: A must-know Alternative to artificial phototherapy.
Sonthalia S
J Cosmet Dermatol; 2021 Jul; 20(7):2141-2147. PubMed ID: 33977652
[TBL] [Abstract][Full Text] [Related]
15. Triple combination therapy of narrowband ultraviolet B, fractional carbon dioxide laser and topical bimatoprost 0.01% for non-segmental vitiligo on non-facial areas: A randomized half-body, double-blind, placebo-controlled, comparative study.
Kanokrungsee S; Khunkhet S; Rojhirunsakool S; Thadvibun K; Sahaspot T
Dermatol Ther; 2022 Jan; 35(1):e15198. PubMed ID: 34750933
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of prostaglandin E2 versus prostaglandin F2 alpha assisted with narrowband-UVB in stable vitiligo.
Neinaa YME; Mahmoud MAE; El Maghraby GM; Ibrahim ZAE
Arch Dermatol Res; 2023 Nov; 315(9):2647-2653. PubMed ID: 37594537
[TBL] [Abstract][Full Text] [Related]
17. A comparative study on the use of fractional CO
Bakr RM; Abdel-Gaber RM; Tawfik YM
Dermatol Ther; 2021 Jan; 34(1):e14604. PubMed ID: 33249712
[TBL] [Abstract][Full Text] [Related]
18. Comparison of NB-UVB combination therapy regimens for vitiligo: A systematic review and network meta-analysis.
Zhu B; Liu C; Zhang L; Wang J; Chen M; Wei Y
J Cosmet Dermatol; 2023 Mar; 22(3):1083-1098. PubMed ID: 36456176
[TBL] [Abstract][Full Text] [Related]
19. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study.
Majid I
Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696
[TBL] [Abstract][Full Text] [Related]
20. NB-UVB plus oral Polypodium leucotomos extract display higher efficacy than NB-UVB alone in patients with vitiligo.
Pacifico A; Damiani G; Iacovelli P; Conic RRZ; ; Gonzalez S; Morrone A
Dermatol Ther; 2021 Mar; 34(2):e14776. PubMed ID: 33433041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
